
|Videos|May 3, 2013
Access to Innovation
In this video, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Advertisement
In this video shot at BIO International Convention 2013, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
3
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5


































































































































